Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: Nigeria has reported 317 confirmed cases in two months, more than the total for all of last year. The World Health Organization says there are 20 suspected cases across the border in Benin. Nigeria has reported 72 deaths so far. There is no vaccine for the hemorrhagic fever, which is transmitted through the bodily fluids of sick people. Humans also can contract the disease by coming into contact with food contaminated by rat excrement. Those with the disease initially present with high fever but in extreme cases can later suffer bleeding from the nose and mouth. Claim: Nigeria reports record high Lassa fever cases with 317.

Output: Health authorities say a Lassa fever outbreak in Nigeria has reached a record high and there are suspected cases in neighboring Benin as well.


Input: Consider Input: Paragraph: The bulk of the money will come from Teva Pharmaceutical Industries Ltd. and its affiliates for paying to delay a generic narcolepsy drug, Provigil, from entering the market for nearly six years. Teva is paying $69 million, which Becerra says is the largest pay-for-delay settlement received by any state. Such agreements let the developer of brand name drugs keep their monopolies over the drugs after their patents expire, thereby letting them continue to charge consumers higher prices. The drug developer pays the generic manufacturer to keep the cheaper version of the drug from entering the marketplace for an agreed period of time. Teva said the money will come from a pre-existing fund that was created in 2015 as part of the company’s settlement with the U.S. Federal Trade Commission over similar claims, and it will not make any additional payments. Becerra said such agreements can force consumers and the health care market to pay as much as 90% more than if there were generic alternatives. More than $25 million of the settlement will go to a consumer fund for California residents who purchased Provigil, Nuvigil or Modafinil between 2006 and 2012. “No one in America should be forced to skip or ration doses of medicine that they need ... and certainly not because a drug company is colluding to keep the price of your drug artificially high even when cheaper options could be available. But that’s what’s happening,” Becerra said. The second, $760,000 settlement is with Teva, Endo Pharmaceuticals and Teikoku Pharma USA over keeping a genetic alternative to the pain patch Lidoderm from entering the market for nearly two years. Teva said it is paying $200,000 to cover the state’s legal costs after settling similar federal claims earlier this year. Neither Endo nor Teikoku responded to requests for comment. Both settlements bar the companies from pay-for-delay agreements for several years. Teva is agreeing to not to enter any such agreements for 10 years, while Endo Pharmaceuticals has an eight-year agreement and Teikoku a 20-year injunction. Teva said the restriction is identical to its federal consent decree. Becerra also backed pending legislation, AB824 by Democratic Assemblyman Jim Wood of Santa Rosa, that would ban such agreements. The measure would require pharmaceutical companies to prove that their agreements are not anticompetitive. It passed the Assembly 56-0 in May and is awaiting a vote in the Senate. Pharmaceutical companies oppose the bill, arguing the Federal Trade Commission already does this monitoring. ___ This story has been corrected to say that while there are four settlement agreements, they involve only three companies. Claim: 3 companies pay California $70 million for delaying drugs.

Output: Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday.


Input: Consider Input: Paragraph: Such an amendment would have been unprecedented among U.S. states, according to the National Conference of State Legislatures. The Democratic-controlled state House approved the measure 35-25 on Feb. 13, but it never reached the floor of the Democratic-controlled Senate for a vote. Sen. Laurie Monnes Anderson, chairwoman of the Senate Health Care Committee, said it was never brought to a vote in committee because it did not appear likely to pass by the entire Senate. “I firmly believe that health care is a right,” Monnes Anderson, a Democrat from the Portland suburb of Gresham, said in an email. “As a retired public health nurse I see how no access to health care affects your ability to keep a job and children to learn.” The amendment to the 160-year-old Constitution would have obliged the state “to ensure that every resident of Oregon has access to cost-effective, medically appropriate and affordable health care as a fundamental right.” Opponents had said there was no plan to fund making health care access a right, and warned that doing so would make the state vulnerable to lawsuits. The League of Women Voters was among the opponents. “The State of Oregon has insufficient income to support its current responsibilities and cannot provide the added cost of health care coverage for all its residents at this time,” it said in written testimony. Lawmakers have wrestled over the issue as the Trump administration has tried to dismantle former President Barack Obama’s health care law. “There were general concerns that there might be a lawsuit or something similar that might force the issue on what is now being touted as an aspirational thing,” said Rick Osborn, spokesman for the Senate Democrats. Senate Majority Leader Ginny Burdick, a Democrat from Portland, said there just wasn’t enough time during the current five-week legislative session to gain critical mass on the measure. “The bill would have needed extensive amendments for it to get the support it needs in the Senate,” Burdick said. ___ Follow Andrew Selsky on Twitter at https://twitter.com/andrewselsky Claim: Oregon effort to declare health care a right falters.


Output: An effort to insert an amendment in Oregon’s Constitution making health care a right died amid concerns by lawmakers that it would expose the state to lawsuits.